The survival of patients with different numbers of harvested lymph nodes.

<p>A The median survival times of patients who had 0–14, 15–30 and more than 30 lymph nodes harvested in the study were 44.94, 46.62 and 42.82 months, respectively (p = 0.003). B The median survival times of patients who had 0–14, 15–30 and more than 30 lymph nodes harvested in the N0 group were 45.43, 54.28 and 66.95 months, respectively (p = 0.068). C The median survival times of patients who had 0–14, 15–30 and more than 30 lymph nodes harvested in the N1 group were 49.22, 44.25 and 56.72 months, respectively (p<0.001). D The median survival times of patients who had 0–14, 15–30 and more than 30 lymph nodes harvested in the N2 group were 43.94, 47.97 and 35.19 months, respectively (p = 0.042). E The median survival times of patients who had 0–14, 15–30 and more than 30 lymph nodes harvested in the N3a group were 32.88, 42.76 and 23.50 months, respectively (p = 0.016). F The median survival times of patients who had 15–30 and more than 30 lymph nodes harvested in the N3b group were 22.48 and 36.0 months, respectively (p = 0.199).